These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Detection of atherosclerotic plaques in ApoE-deficient mice using (99m)Tc-duramycin. Liu Z; Larsen BT; Lerman LO; Gray BD; Barber C; Hedayat AF; Zhao M; Furenlid LR; Pak KY; Woolfenden JM Nucl Med Biol; 2016 Aug; 43(8):496-505. PubMed ID: 27236285 [TBL] [Abstract][Full Text] [Related]
4. SPECT and fluorescence imaging of vulnerable atherosclerotic plaque with a vascular cell adhesion molecule 1 single-chain antibody fragment. Liu C; Zhang X; Song Y; Wang Y; Zhang F; Zhang Y; Zhang Y; Lan X Atherosclerosis; 2016 Nov; 254():263-270. PubMed ID: 27680307 [TBL] [Abstract][Full Text] [Related]
5. Selective Imaging of Vascular Endothelial Growth Factor Receptor-1 and Receptor-2 in Atherosclerotic Lesions in Diabetic and Non-diabetic ApoE Tekabe Y; Johnson LL; Rodriquez K; Li Q; Backer M; Backer JM Mol Imaging Biol; 2018 Feb; 20(1):85-93. PubMed ID: 28421362 [TBL] [Abstract][Full Text] [Related]
6. Targeted ED-B fibronectin SPECT in vivo imaging in experimental atherosclerosis. Dietrich T; Berndorff D; Heinrich T; Hucko T; Stepina E; Hauff P; Dinkelborg LM; Atrott K; Giovannoni L; Neri D; Fleck E; Graf K; Menssen HD Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):228-37. PubMed ID: 25864530 [TBL] [Abstract][Full Text] [Related]
7. Imaging α Cook GJR; Azad GK; Taylor BP; Lee E; Morrison MS; Hughes S; Morris S; Rudman S; Chowdhury S; Goh V Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):898-903. PubMed ID: 29396636 [TBL] [Abstract][Full Text] [Related]
8. Specific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1. De Vos J; Mathijs I; Xavier C; Massa S; Wernery U; Bouwens L; Lahoutte T; Muyldermans S; Devoogdt N Mol Imaging Biol; 2014 Oct; 16(5):690-8. PubMed ID: 24687730 [TBL] [Abstract][Full Text] [Related]
9. Detecting Vulnerable Atherosclerotic Plaques by Jiang L; Zhu H; Li Y; Wu X; Wang H; Cheng Z Mol Pharm; 2019 Mar; 16(3):1350-1357. PubMed ID: 30742442 [TBL] [Abstract][Full Text] [Related]
10. A Comparison of [ Hu Y; Liu G; Zhang H; Li Y; Gray BD; Pak KY; Choi HS; Cheng D; Shi H Mol Imaging Biol; 2018 Apr; 20(2):249-259. PubMed ID: 28785938 [TBL] [Abstract][Full Text] [Related]
11. Imaging of atherosclerosis in apoliprotein e knockout mice: targeting of a folate-conjugated radiopharmaceutical to activated macrophages. Ayala-López W; Xia W; Varghese B; Low PS J Nucl Med; 2010 May; 51(5):768-74. PubMed ID: 20395331 [TBL] [Abstract][Full Text] [Related]
15. In vivo molecular imaging of atherosclerotic lesions in ApoE-/- mice using VCAM-1-specific, 99mTc-labeled peptidic sequences. Dimastromatteo J; Broisat A; Perret P; Ahmadi M; Boturyn D; Dumy P; Fagret D; Riou LM; Ghezzi C J Nucl Med; 2013 Aug; 54(8):1442-9. PubMed ID: 23719858 [TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro evidence that ⁹⁹mTc-HYNIC-interleukin-2 is able to detect T lymphocytes in vulnerable atherosclerotic plaques of the carotid artery. Glaudemans AW; Bonanno E; Galli F; Zeebregts CJ; de Vries EF; Koole M; Luurtsema G; Boersma HH; Taurino M; Slart RH; Signore A Eur J Nucl Med Mol Imaging; 2014 Sep; 41(9):1710-9. PubMed ID: 24737117 [TBL] [Abstract][Full Text] [Related]
17. Imaging VEGF Receptors and α Tekabe Y; Li Q; Zhang G; Johnson J; Schmidt AM; Backer M; Backer J; Johnson LL Mol Imaging Biol; 2018 Dec; 20(6):963-972. PubMed ID: 29687324 [TBL] [Abstract][Full Text] [Related]